Abstract To evaluate whether Palmitoyl-pentapeptide (Pal-KTTKS), a lipidated subfragment of type 1 pro-collagen (residues 212-216), plays a role in fibroblast contractility, the effect of Pal-KTTKS on the expression of pro-fibrotic mediators in hypertropic scarring were investigated in relation with trans-differentiation of fibroblast to myofibroblast, an icon of scar formation. a-SMA was visualized by immunofluorescence confocal microscopy with a Cy-3-conjugated monoclonal antibody. The extent of a-SMA-positive fibroblasts was determined in collagen lattices and in cell culture study. Pal-KTTKS (0-0.5 lM) induced CTGF and a-SMA protein levels were determined by western blot analysis and fibroblast contractility was assessed in three-dimensional collagen lattice contraction assay. In confocal analysis, fibroblasts were observed as elongated and spindle shapes while myofibroblast observed as squamous, enlarged cells with pronounced stress fibers. Without Pal-KTTKS treatment, three quarters of the fibroblasts differentiates into the myofibroblast; a-SMApositive stress fibers per field decreased twofold with 0.1 lM Pal-KTTKS treatment (75 ± 7.1 vs 38.6 ± 16.1%, n = 3, p \ 0.05). The inhibitory effect was not significant in 0.5 lM Pal-KTTKS treatment. Stress fiber level and collagen contractility correlates with a-SMA expression level. In conclusion, Pal-KTTKS (0.1 lM) reduces a-SMA expression and trans-differentiation of fibroblasts to myofibroblast. The degree of reduction is dose-dependent. An abundance of myofibroblast and fibrotic scarring is correlated with excessive levels of a-SMA and collagen contractility. Delicate balance between the wound healing properties and pro-fibrotic abilities of pentapeptide KTTKS should be considered for selecting therapeutic dose for scar prevention.
Introduction
A sub-fragment of type-1 collagen with a minimum necessary sequence of KTTKS (Lys-Thr-Thr-Lys-Ser, MW = 563.64, Log P = -3.27) has been reported to increase collagen production in fibroblasts [1] [2] [3] . In present, there are still contradiction regarding the effect of KTTKS on the tissue regeneration and dermal wound healing process [4, 5] . Whether continuous exposure to KTTKS would improve the cosmetic appearance and wound healing process still needs to be clarified [6] [7] [8] . To increase the skin penetration, attachment of palmitic acid to the N-terminal group of lysine through the formation of amide was introduced as a palmitoyl-KTTKS (Pal-KTTKS, MW = 802.05, Log P = 3.32). Regarding the biological mechanism, there's limited information in the literature. Most of the reported clinical benefits were obtained by using a formulation containing palmitoyl-KTTKS and other active ingredients combined. Previous in vivo published studies did not differentiate the role of Pal-KTTKs with other ingredients presence in the formulation. Thus the reported beneficial clinical effects could not be readily verified [9] .
Regulation of collagen synthesis and deposition is a direct approach to the control of scar tissue formation [10] . Connective Tissue Growth Factor (CTGF) in early wound healing stage has beneficial effect in collagen production and proper organizing and epithelialization [11] [12] [13] . However, sustained over-expression of CTGF induced fibrosis CTGF elevation has been implicated in number of fibrotic lesions [14, 15] . Recent studies have demonstrated that in addition to its direct effect on extracellular matrix turnover, it may stimulate fibroblast--myofibroblast differentiation, as it is capable of up-regulating a-SMA in fibroblast. During normal wound repair, myofibroblasts are transiently present at the wound site causing wound contraction and restoration of tissue integrity [16, 17] . Once the wound had regained normal structure and function, myofibroblasts disappear by apoptosis. However, in pathological states, myofibroblasts persists and produce excess of extracellular matrix deposition and tissue deformation leading to scarring [18, 19] . Even though myofibroblasts are crucial for proper wound repair, their timely disappearance is crucial for preventing undesirable scarring process [20, 21] .
In this study, we investigated how palmitoyl-pentapeptide (Pal-KTTKS) could modify the outcome of wound healing, scar disposition. The effect of Pal-KTTKS on a-SMA and CTGF, a pro-fibrotic mediators involved in hyper-tropic scarring were investigated in relation with modulation of trans-differentiation of fibroblast to myofibroblast, the most reliable marker of hypertropic scar formation.
Materials and methods

Materials
All chemicals were purchased from Sigma chemicals (MO, USA). Human dermal fibroblast was provided from dept. dermatology, Seoul National University. Pal-KTTKS pentapeptide was purchased from Peptron Co. (Daejeon, Korea). DMEM (Dulbecco's Modified Eagle Medium) culture medium and FBS (fetal bovine serum) were purchased from Cellgro (Washington DC, USA), PS (Penicillin Streptomycin) was purchased from Gibco (NY, USA) and Cultrex Ò Rat Collagen I was purchased from Trevigen (MD, USA).
Cell lines
Primary human foreskin fibroblasts were cultured in a 6 well plate (5 9 10 5 cells/well) in DMEM medium supplemented with 10% heat inactivated fetal bovine serum and 100 units/mL penicillin/streptomycin. Cells were maintained in a humidified atmosphere with 95% air and 5% CO 2 at 37°C.
In vitro wound healing study
In vitro fibroblast wound model was prepared as reported previously [22] . In brief, cells were plated in six-well plates at 1 9 10 5 cells/well confluence and grown for 24 h. After scratching with a sterile 10 lL micro tip, cells were treated with Pal-KTTKS for predetermined time points (3-6 h) in incubator. After treating with Pal-KTTKS, cell morphology, cell migration and proliferation were observed and images were captured and analyzed with Olympus microscopy system composed of an inverted microscope (OLYMPUS CK40-F200) and Camera (Olympus DP-21, Japan). Wound closure areas were quantified by using Analysis TS Auto Olympus soft imaging solution GmbH program at predetermined post injury time. Digitized images were captured with an inverted microscope (Olympus CK40-F200, Japan) and digital camera (Olympus DP21, Japan) (objective lens 9 10, eyepiece 9 10) expose time 2000 ms, sensitivity ISO100 (9100).
CTGF immunoblot analysis
After 6 h Pal-KTTKS treatment, cells were rinsed with cold PBS and lysed in SDS-lysis buffer. Equal amounts of protein extracts in SDS-lysis buffer were subjected to 12% SDS-PAGE analysis and electrophoretically transferred to nitrocellulose membrane. Anti-CTGF antibody was purchased from Santa Cruz (CA, USA). b-actin antibody was from Sigma-Aldrich (MO, USA). Enhanced chemiluminescence (Amersham Pharmacia, Buckinghamshire, U.K.) system was used for detection. Relative intensity of the bands were determined by an Image Analyzer Gel Logic 200 Imaging System (NY, USA).
a-SMA western blot analysis
After scratching with a sterile 10 lL micro tip, cells were cultured with and without Pal-KTTKS in the absence of fetal bovine serum (FBS). The cells are washed 2-3 times with cold PBS. Each well was added 70-80 lL lysis buffer (1 M tris (pH 6.8) 500 lL, 10% SDS 2 mL, 0.5 M EDTA (pH 8.0) 20 lL, 1 M DDT 1 mL, protease inhibitor 1tab, D.W 5.48 mL; total 10 mL) to prepare a supernatant. The concentration of the supernatant was measured by Bradford method using Protein Assay Reagent (Bio-Rad, USA). The protein were separated by SDS-PAGE (10% polyacrylamide), transferred onto PVDF membrane and probed with specific polyclonal antibodies and secondary antibodies. Protein-antibody complexes were visualized by the enhanced chemiluminescence detection system (Amersham Pharmacia, Buckinghamshire, UK).
Collagen lattice contraction
After the cells were cultured with and without Pal-KTTKS for 6 h, control and Pal-KTTKS treated cells were trypsinized. Collagen lattice contraction was prepared with 1.4 mL bovine dermal collagen and 0.4 mL 59 DMEM (Sigma, USA) and then making the pH to 7.2-7.5 with NaOH. And 0.2 mL of the cell suspension (containing 5 9 10 5 cells) was added to the dermal collagen solution. Before making collagen mixture, six-well plate was coated with BSA for 1 h in incubator. Place the 2 mL collagen mixture into a well of the six-well plate, then, BSA was removed. Collagen lattices were allowed to gel for 60 min in an atmosphere with 95% air and 5% at 37°C. After 60 min, the collagen lattices were detached from the surface of the well by rimming the lattice with a sterile spatula. The 4 mL of serum-free medium (SFM) was added to each well. And the rate of contraction was determined by measuring lattice diameter at predetermined time.
Confocal immuno-fluorescence analysis
The cells were plated in 8-well-slide glass at 2.0 9 10 4-cells/well (250 lL) confluence and grown for 16 h. After scratching with 0.5-10 lL micro tips, the cells were cultured with and without Pal-KTTKS for 6 h in incubator. And then tested fibroblast samples were fixed in 3.7% formaldehyde for 1 h and washed twice in PBS and then placed in 1% Triton X-100 (300 lL/well) for 15 min and blocked with 10% FBS for 1 h at room temperature. Following sample preparation, immunohistochemistry was performed for the detection of a-SMA using indirect immunofluorescence with the primary antibody against a-SMA, monoclonal anti-a-SMA-Cy3 conjugated (Sigma, USA) at a dilution of 1:200 in FBS for 16 h in incubator. Slides were washed twice in PBS. Treated samples were exposed to 4, 6-diamidino-2-phenylinodole (DAPI) (Sigma, USA) staining solution at a dilution of 1:5000 for 1 min. DAPI is a blue fluorescent nuclear stain, and this step was ensured to visualize nuclei. The slides were washed twice in PBS, mounted in antifade reagent 10 lL and fixed it with cover slips. Images were viewed with a confocal laser-scanning microscope, Zeiss Laser Confocal Microscope (ZEISS-LSM 700, Jena, Germany).
Statistical analysis
Numerical results are presented as the mean ± SD of all experiments. Mean values were tested by a Student's t test. Differences were considered to be statistically significant at p values p \ 0.05 indicated by an asterisk (**). The positive linear correlation between fibroblast contraction and a-SMA expression was statistically tested. 
Effect of KTTKS on the trans-differentiation of fibroblasts to myofibroblasts
Effect of Pal-KTTKS on the trans-differentiation of fibroblast to myofibroblast was investigated in human dermal fibroblast wound model. Figure 1A -C show phase contrast Images of scratched dermal fibroblasts at 30 h post injury time without (0 lM) or with Pal-KTTKS treatment (0.1 or 0.5 lM). In serum-free media (SFM), Pal-KTTKS untreated conditions, large squamous polygonal myofibroblasts (arrow) were observed (Fig. 1A) . In Pal-KTTKS treated cells (0.1 lM)), mostly typical biaxial spindleshaped fibroblasts (arrow) were observed (Fig. 1B) . This result clearly demonstrates the inhibitory effect of Pal-KTTKS (0.1 lM) on the trans-differentiation of fibroblasts into myofibroblasts. However, Fig. 1C shows the enlarged squamous myofibroblast cells (arrow) still present at higher dose of Pal-KTTKS (0.5 lM). 
Effect of KTTKS on the expression of cytokines
Alpha smooth muscle actin (a-SMA)
Effect of Pal-KTTKS on a-SMA expression was studied at different concentration ranges (0-0.5 lM). To understand how the scratch wound condition increase the a-SMA expression, un-wounded fibroblasts were studied as a comparison. Figure 3A shows western blot analysis of a-SMA in fibroblasts in response to different concentrations of Pal-KTTKS treatment. Non-wounded (normal) cells express negligible a-SMA. Wounded fibroblasts up regulate a-SMA expression more than twofold. Expression of a-SMA relative to ß-actin, normalized to non-wound is summarized in Fig. 3B . The expression of a-SMA was reduced by 62% (p \ 0.05) in 0.1 lM treated cells as compared to non treatment (0 lM).
Collagen lattice contraction
The fibroblast-populated collagen lattice (FPCL) contraction assay was used to examine that Pal-KTTKS could alter fibroblast-mediated contraction of collagen lattices. Figure 4A shows that Pal-KTTKs inhibited FPCL contraction in a dose-dependent manner. Pal-KTTKS treatment (0.1 lM) induced a decrease in contraction rate as compared to the untreated cells. Figure 4B shows the percentage of contraction of FPCL when they were treated with different concentrations of Pal-KTTKS (0-0.5 lM). Without Pal-KTTKS treatment, FPCL maintained its initial diameter (78.59 ± 0.85%). Pal-KTTKS treatment (0.1 lM) maintained its initial diameter (84.92 ± 0.43%). The degree of collagen contraction is correlated with a-SMA expression level.
Confocal immunofluorescence analysis
Myofibroblasts are highly contractile cells with prominent stress fibers. Expression of a-SMA is considered as the most reliable marker of myofibroblasts [16, 20] . Confocal immune-fluorescence analysis was conducted to observe the expression of a-SMA.
Non wound 0µM 0.1µM 0.5µM Figure 5A shows representative confocal sections of immune-fluorescence staining for a-SMA (red) and nuclear staining (blue) with DAPI. Normal, non wound cells exhibit basal negligent level of a-SMA staining (Nonwound), while the untreated cells (0 lM) exhibited cellular hypertrophy and squamous morphology with strong staining of a-SMA and more pronounced actin stress fibers. In the overlaid confocal sections without Pal-KTTKS treatment, abundance of a-SMA were presented (75.0 ± 7.1%, n = 3). Pal-KTTKS treated (0.1 lM) cells show negligible a-SMA staining. In higher concentration (0.5 lM) of Pal-KTTKS treated cells, a-SMA positive stress fibers were increased. Calculation of the a-SMA expression ratio (number of a-SMA expressed cells/ number of DAPI stained cells) was summarized in Fig. 5B . The expression of a-SMA was dependent on the concentration of Pal-KTTKS treatment. After scarring, a-SMA expressing cells increased to twofold (p \ 0.05) and Pal-KTTKS treatment (0.1 lM) reduced the level of a-SMA to (38.6 ± 16.1%, n = 3, p \ 0.05) as compared to untreated cells. The extent of a-SMA inhibition was leveled down as the Pal-KTTKS concentration was further increased to 0.5 lM.
Discussion
Collagen is the most abundant protein in mammals and it is a key component of the extracellular matrix [23] . Controlling its production is the key element in tissue regeneration. In regenerative healing (without scarring), myofibroblast usually disappear by apoptosis. However, in pathological states such as hypertropic scars, the persistence of myofibroblasts contributes to overproduction of extracellular matrix (ECM), excessive a-SMA expression and contraction. To reduce the size of an open wound without scarring, delicate balance between the formation of connective tissue and degradation of excessive extracellular collagen matrix deposition is crucial [24, 25] . As the crucial balance between collagen production and breakdown disrupted, proliferative scarring occurred. Rinkevich and coworkers investigated the effects of inhibiting dipeptidyl peptidase, a cell surface serine exopeptidase on scar formation during wound healing using a small molecule (diprotin A) and observed that faster wound closure implies that there are higher extra collagen matrix disposition (scar) occurs [26] . Mas-Chamberlin proposed a very insightful explain how breakdown product of collagen can play a role in wound healing process. He claimed that nature is economical and we can learn from her. During the wound healing process, macromolecules such as collagen, elastin, are broken down into smaller fragments by collagenase, elastase. The breakup of collagen is not random, however, oligopeptide fragments of defined amino acid sequence are released with biological signaling activity like local hormones [27] . Some specific fragments either stimulate or inhibit collagen neosynthesis in the fibroblasts to speed up the tissue repair process. The less inhibitory effect at high concentration (0.5 lM) of Pal-KTTKS treated group correlates with faster wound closure and higher a-SMA expression [25] . The role of Pal-KTTKS in relation to growth factors and cell migration during wound healing needs further investigation. Our study claims for optimizing dose of Pal-KTTKS for anti scar therapy. Future studies focusing on the concentration range from 0.01 to 1.0 lM of Pal-KTTKS and understanding the self-assembling nano-fibrillar structure of this amphiphilic peptide and its structural transition and its extracellular matrix degradation property depending on concentration [28, 29] could provide us an insight to determine how delicate balance between the wound healing properties and pro-fibrotic abilities of pentapeptide KTTKs is achieved. In addition, considering significant barrier property of stratum corneum, the outer most layer of the skin and extensive protease present in dermis, dermal bioavailability of Pal-KTTKS should be very minimal [30] . In this sense, topical application of high concentration of Pal-KTTKS may not cause serious adverse effects. However, when Pal-KTTKs is administered as an injection or microneedle type delivery system, which can directly expose this collagen stimulating penta-peptide (KTTKS) to the dermis, dose should be carefully considered.
In conclusion, Pal-KTTKS (0.1 lM), a pentapeptide from type I procollagen reduces a-SMA expression and trans-differentiation of fibroblasts to myofibroblast. The degree of reduction is dose-dependent. At higher concentration (0.5 lM) of Pal-KTTKS, pro-fibrotic mediator, a-SMA expression remains high. Delicate balance between the wound healing properties and pro-fibrotic abilities of pentapeptide KTTKS should be considered for selecting therapeutic dose for wound healing.
